HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Oncologists seek to optimize a transformed landscape in melanoma treatment Jennifer Byrne
-
- Are genetic expression profiling tests ready for widespread use in melanoma?
- The accidental ‘stupidpower’ — It is what it is Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- Tips for APPs on using TACE, TAE for hepatocellular carcinoma Lisa Parks, MS, APRN-CNP, ANP-BC
- Digital mammography fails to improve detection of deadly breast cancers Jennifer Byrne
- Surveillance imaging after surgery for glioblastoma does not appear to improve outcomes Jennifer R. Southall
- Delays in cancer diagnoses amid COVID-19 signal downstream effect on long-term outcomes Jennifer R. Southall
- COVID-19 pandemic causing ‘unprecedented disruption’ in cancer research, Fauci says Jennifer R. Southall
- COVID-19 may lead to 10,000 excess deaths due to breast, colorectal cancers Mark Leiser
-
- AACR forum confronts racism, inequality in research Jennifer Byrne
- BCMA-targeted CAR-T shows ‘outstanding responses’ in advanced multiple myeloma Drew Amorosi
- Adding pembrolizumab to chemotherapy improves outcomes in metastatic NSCLC John DeRosier
- Tool appears to predict need for treatment in asymptomatic, early-stage CLL Jennifer R. Southall
- Cancer survivors report higher perceived vs. actual diet quality Jennifer R. Southall
- FDA grants fast track status to enzastaurin for newly diagnosed glioblastoma
- The University of Texas MD Anderson Cancer Center again ranked best cancer hospital in US